Gynecological CANCER

Study Title

Acquisition of Human Gynecologic Specimens to be Used in Studying the Causes, Diagnosis, Prevention and Treatment of Cancer

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

ChemoFx® PRO - A Post-Market Data Collection Study Utilizing Physician Reported Outcomes

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, In Stage IVB, Recurrent or Persistent Carcinoma of the Cervix

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma NCI-Supplied Agent(s): Bevacizumab (NSC #704865, IND #7921)

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

NURSE-DELIVERED WRITE SYMPTOMS© vs. SELF-DIRECTED WRITE SYMPTOMS© vs. CARE AS USUAL FOR OPTIMAL SYMPTOM MANAGEMENT FOR WOMEN WITH RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

A Randomized, Double-blind, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Weekly MORAb-003 in Combination With Carboplatin and Taxane in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse

Principal Investigator:

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)

Study Title

A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus

Principal Investigator: John Comerci, M.D.

Please also contact study coordinator for more information:    

Mykie Bianchi, CCRC (Phone 412-578-4316)